{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:09:29Z","timestamp":1777392569211,"version":"3.51.4"},"reference-count":134,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["101BX003328-01"],"award-info":[{"award-number":["101BX003328-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma as a very aggressive type of cancer is still in urgent need of improved treatment. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and arginine deiminase (ADI-PEG20) are two of many suggested drugs for treating melanoma. Both have shown anti-tumor activities without harming normal cells. However, resistance to both drugs has also been noted. Studies on the mechanism of action of and resistance to these drugs provide multiple targets that can be utilized to increase the efficacy and overcome the resistance. As a result, combination strategies have been proposed for these drug candidates with various other agents, and achieved enhanced or synergistic anti-tumor effect. The combination of TRAIL and ADI-PEG20 as one example can greatly enhance the cytotoxicity to melanoma cells including those resistant to the single component of this combination. It is found that combination treatment generally can alter the expression of the components of cell signaling in melanoma cells to favor cell death. In this paper, the signaling of TRAIL and ADI-PEG20-induced arginine deprivation including the main mechanism of resistance to these drugs and exemplary combination strategies is discussed. Finally, factors hampering the clinical application of both drugs, current and future development to overcome these hurdles are briefly discussed.<\/jats:p>","DOI":"10.3390\/ijms22147628","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T10:52:58Z","timestamp":1626432778000},"page":"7628","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma"],"prefix":"10.3390","volume":"22","author":[{"given":"Chunjing","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Veterans Affairs, Miami VA Healthcare System, Research Service, Miami, FL 33125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"You","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Department of Surgery, Cardiothoracic Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhi","family":"Wangpaichitr","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Miami VA Healthcare System, Research Service, Miami, FL 33125, USA"},{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Department of Surgery, Cardiothoracic Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Miami VA Healthcare System, Research Service, Miami, FL 33125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn G.","family":"Feun","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Department of Medicine, Hematology\/Oncology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macus T.","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niramol","family":"Savaraj","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Miami VA Healthcare System, Research Service, Miami, FL 33125, USA"},{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Department of Medicine, Hematology\/Oncology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family","volume":"271","author":"Pitti","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and Characterization of a New Member of the TNF Family That Induces Apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and Antitumor Activity of Recombinant Soluble Apo2 Ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.cr.7290311","article-title":"Expression of TRAIL and TRAIL Receptors in Normal and Malignant Tissues","volume":"15","author":"Daniels","year":"2005","journal-title":"Cell Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.cr.7290236","article-title":"Following a TRAIL: Update on a Ligand and Its Five Receptors","volume":"14","author":"Kimberley","year":"2004","journal-title":"Cell Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and Its Death and Decoy Receptors","volume":"10","author":"LeBlanc","year":"2003","journal-title":"Cell Death Differ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1091\/mbc.e04-01-0059","article-title":"The Role of Osteoprotegerin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Microvascular Endothelial Cell Survival","volume":"15","author":"Pritzker","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential Regulation of TRAIL and CD95 Ligand in Transformed Cells of the T and B Lymphocyte Lineage","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488709787047530","article-title":"TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges","volume":"4","author":"Bellail","year":"2009","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_12","first-page":"421","article-title":"Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 2 (TRAIL-R2) Induces Apoptosis in Primary Renal Cell Carcinoma Cells in Vitro and Inhibits Tumor Growth in Vivo","volume":"28","author":"Zeng","year":"2006","journal-title":"Int. J. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0083-6729(04)67007-5","article-title":"TRAIL and NFkappaB Signaling\u2014A Complex Relationship","volume":"67","author":"Wajant","year":"2004","journal-title":"Vitam. Horm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","article-title":"Apo2L\/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5","volume":"12","author":"Kischkel","year":"2000","journal-title":"Immunity"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"46639","DOI":"10.1074\/jbc.M105102200","article-title":"Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8","volume":"276","author":"Kischkel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors","volume":"94","author":"Luo","year":"1998","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/35101078","article-title":"How Melanoma Cells Evade Trail-Induced Apoptosis","volume":"1","author":"Hersey","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J. Immunol."},{"key":"ref_20","first-page":"2747","article-title":"Relation of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptor and FLICE-Inhibitory Protein Expression to TRAIL-Induced Apoptosis of Melanoma","volume":"59","author":"Zhang","year":"1999","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/sj.onc.1210134","article-title":"Resistance of Melanoma Cells to TRAIL Does Not Result from Upregulation of Antiapoptotic Proteins by NF-KappaB but Is Related to Downregulation of Initiator Caspases and DR4","volume":"26","author":"Kurbanov","year":"2007","journal-title":"Oncogene"},{"key":"ref_22","first-page":"917","article-title":"Homozygous Deletion of the Death Receptor DR4 Gene in a Nasopharyngeal Cancer Cell Line Is Associated with TRAIL Resistance","volume":"16","author":"Ozoren","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.onc.1210655","article-title":"Reversal of Methylation Silencing of Apo2L\/TRAIL Receptor 1 (DR4) Expression Overcomes Resistance of SK-MEL-3 and SK-MEL-28 Melanoma Cells to Interferons (IFNs) or Apo2L\/TRAIL","volume":"27","author":"Bae","year":"2008","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1871520620666200130091955","article-title":"Knockdown of Enhancer of Zeste Homolog 2 Affects MRNA Expression of Genes Involved in the Induction of Resistance to Apoptosis in MOLT-4 Cells","volume":"20","author":"Naimi","year":"2020","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nm1627","article-title":"Death-Receptor O-Glycosylation Controls Tumor-Cell Sensitivity to the Proapoptotic Ligand Apo2L\/TRAIL","volume":"13","author":"Wagner","year":"2007","journal-title":"Nat. Med."},{"key":"ref_26","first-page":"176","article-title":"C-FLIP, a Master Anti-Apoptotic Regulator","volume":"34","author":"Safa","year":"2012","journal-title":"Exp. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.cdd.4401416","article-title":"Downregulation of Bcl-2, FLIP or IAPs (XIAP and Survivin) by SiRNAs Sensitizes Resistant Melanoma Cells to Apo2L\/TRAIL-Induced Apoptosis","volume":"11","author":"Bae","year":"2004","journal-title":"Cell Death Differ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1038\/sj.onc.1210985","article-title":"Suppression of CFLIP Is Sufficient to Sensitize Human Melanoma Cells to TRAIL- and CD95L-Mediated Apoptosis","volume":"27","author":"Geserick","year":"2008","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1038\/sj.onc.1209738","article-title":"Imatinib Enhances Human Melanoma Cell Susceptibility to TRAIL-Induced Cell Death: Relationship to Bcl-2 Family and Caspase Activation","volume":"25","author":"Richon","year":"2006","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/onc.2016.215","article-title":"USP8 Suppresses Death Receptor-Mediated Apoptosis by Enhancing FLIPL Stability","volume":"36","author":"Jeong","year":"2017","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/cdd.2013.179","article-title":"Selective CDK9 Inhibition Overcomes TRAIL Resistance by Concomitant Suppression of CFlip and Mcl-1","volume":"21","author":"Lemke","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.intimp.2015.06.024","article-title":"The Overriding of TRAIL Resistance by the Histone Deacetylase Inhibitor MS-275 Involves c-Myc up-Regulation in Cutaneous, Uveal, and Mucosal Melanoma","volume":"28","author":"Venza","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yexcr.2004.11.002","article-title":"Inhibition of CaMKII-Mediated c-FLIP Expression Sensitizes Malignant Melanoma Cells to TRAIL-Induced Apoptosis","volume":"304","author":"Xiao","year":"2005","journal-title":"Exp. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/sj.onc.1207373","article-title":"Regulation of Apoptosis Proteins in Cancer Cells by Ubiquitin","volume":"23","author":"Zhang","year":"2004","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0960-9822(00)00781-8","article-title":"ML-IAP, a Novel Inhibitor of Apoptosis That Is Preferentially Expressed in Human Melanomas","volume":"10","author":"Vucic","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_36","first-page":"7339","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis of Human Melanoma Is Regulated by Smac\/DIABLO Release from Mitochondria","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/sj.jid.5701185","article-title":"IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L) and Survivin","volume":"128","author":"Hilmi","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sarif, Z., Tolksdorf, B., Fechner, H., and Eberle, J. (2020). Mcl-1 Targeting Strategies Unlock the Proapoptotic Potential of TRAIL in Melanoma Cells. Mol. Carcinog.","DOI":"10.1002\/mc.23253"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1038\/cddis.2012.198","article-title":"Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by BMS-345541 Correlates with Altered Phosphorylation and Activation of Bax","volume":"4","author":"Berger","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1038\/cddis.2013.344","article-title":"ROS-Dependent Phosphorylation of Bax by Wortmannin Sensitizes Melanoma Cells for TRAIL-Induced Apoptosis","volume":"4","author":"Quast","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejcb.2013.11.003","article-title":"Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by Activation of Mitochondrial Pathways via Bax","volume":"93","author":"Quast","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Eberle, J. (2019). Countering TRAIL Resistance in Melanoma. Cancers, 11.","DOI":"10.3390\/cancers11050656"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","article-title":"Sensitization for Death Receptor- or Drug-Induced Apoptosis by Re-Expression of Caspase-8 through Demethylation or Gene Transfer","volume":"20","author":"Fulda","year":"2001","journal-title":"Oncogene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1038\/jid.2015.250","article-title":"Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins","volume":"135","author":"Quast","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.4049\/jimmunol.1302532","article-title":"Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL\/DR5 Pathway","volume":"192","author":"Jazirehi","year":"2014","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1002\/jcp.28029","article-title":"Promotion of TRAIL\/Apo2L-Induced Apoptosis by Low-Dose Interferon-\u03b2 in Human Malignant Melanoma Cells","volume":"234","author":"Kazaana","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1158\/1078-0432.CCR-15-0293","article-title":"Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand\/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models","volume":"21","author":"Liu","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/onc.2015.97","article-title":"Inhibition of B-Raf\/MEK\/ERK Signaling Suppresses DR5 Expression and Impairs Response of Cancer Cells to DR5-Mediated Apoptosis and T Cell-Induced Killing","volume":"35","author":"Oh","year":"2016","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"16081","DOI":"10.1038\/cddiscovery.2016.81","article-title":"HvTRA, a Novel TRAIL Receptor Agonist, Induces Apoptosis and Sustained Growth Retardation in Melanoma","volume":"2","author":"Fleten","year":"2016","journal-title":"Cell Death Discov."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/jid.2013.347","article-title":"RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells","volume":"134","author":"Berger","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1202390","DOI":"10.1080\/2162402X.2016.1202390","article-title":"Programmed Death Ligand 1 (PD-L1)-Targeted TRAIL Combines PD-L1-Mediated Checkpoint Inhibition with TRAIL-Mediated Apoptosis Induction","volume":"5","author":"Hendriks","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jso.24490","article-title":"Arginine-Dual Roles as an Onconutrient and Immunonutrient","volume":"115","author":"Albaugh","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.advms.2018.08.018","article-title":"Metabolic Pathways of L-Arginine and Therapeutic Consequences in Tumors","volume":"64","author":"Szefel","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cncr.20057","article-title":"Incidence and Distribution of Argininosuccinate Synthetase Deficiency in Human Cancers: A Method for Identifying Cancers Sensitive to Arginine Deprivation","volume":"100","author":"Dillon","year":"2004","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/13543784.15.7.815","article-title":"Pegylated Arginine Deiminase: A Novel Anticancer Enzyme Agent","volume":"15","author":"Feun","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","article-title":"Pegylated Arginine Deiminase Treatment of Patients with Unresectable Hepatocellular Carcinoma: Results from Phase I\/II Studies","volume":"22","author":"Izzo","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2867-9-9","article-title":"Pegylated Derivatives of Recombinant Human Arginase (RhArg1) for Sustained in Vivo Activity in Cancer Therapy: Preparation, Characterization and Analysis of Their Pharmacodynamics in Vivo and in Vitro and Action upon Hepatocellular Carcinoma Cell (HCC)","volume":"9","author":"Tsui","year":"2009","journal-title":"Cancer Cell Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1152\/ajpendo.90645.2008","article-title":"Amino Acid Regulation of TOR Complex 1","volume":"296","author":"Avruch","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2013.01.004","article-title":"Nutrient Signaling to MTOR and Cell Growth","volume":"38","author":"Jewell","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1257132","article-title":"Metabolism. Lysosomal Amino Acid Transporter SLC38A9 Signals Arginine Sufficiency to MTORC1","volume":"347","author":"Wang","year":"2015","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31582","DOI":"10.1074\/jbc.M506736200","article-title":"Autophagy Is Required for Maintenance of Amino Acid Levels and Protein Synthesis under Nitrogen Starvation","volume":"280","author":"Onodera","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41586-018-0697-7","article-title":"Autophagy Maintains Tumour Growth through Circulating Arginine","volume":"563","author":"Xie","year":"2018","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/156652410791316995","article-title":"Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma","volume":"10","author":"Savaraj","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11010-012-1518-1","article-title":"TRAIL Induces Autophagic Protein Cleavage through Caspase Activation in Melanoma Cell Lines under Arginine Deprivation","volume":"374","author":"You","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","article-title":"Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/cddis.2012.83","article-title":"Promoter Methylation of Argininosuccinate Synthetase-1 Sensitises Lymphomas to Arginine Deiminase Treatment, Autophagy and Caspase-Dependent Apoptosis","volume":"3","author":"Delage","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/cddis.2012.197","article-title":"Epigenetic Status of Argininosuccinate Synthetase and Argininosuccinate Lyase Modulates Autophagy and Cell Death in Glioblastoma","volume":"4","author":"Syed","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/bjc.2011.524","article-title":"Arginine Deiminase PEG20 Inhibits Growth of Small Cell Lung Cancers Lacking Expression of Argininosuccinate Synthetase","volume":"106","author":"Kelly","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e2406","DOI":"10.1038\/cddis.2016.232","article-title":"A Metabolic Synthetic Lethal Strategy with Arginine Deprivation and Chloroquine Leads to Cell Death in ASS1-Deficient Sarcomas","volume":"7","author":"Bean","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"ra31","DOI":"10.1126\/scisignal.2004761","article-title":"Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells","volume":"7","author":"Qiu","year":"2014","journal-title":"Sci. Signal."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00253-013-5118-0","article-title":"Involvement of Autophagy in Recombinant Human Arginase-Induced Cell Apoptosis and Growth Inhibition of Malignant Melanoma Cells","volume":"98","author":"Wang","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular Basis and Current Strategies of Therapeutic Arginine Depletion for Cancer","volume":"139","author":"Fultang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, Autophagy, and Mitochondria Crosstalk Underlies the ER Stress Response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biocel.2015.10.027","article-title":"Arginine Deprivation Induces Endoplasmic Reticulum Stress in Human Solid Cancer Cells","volume":"70","author":"Bobak","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1089\/ars.2009.2625","article-title":"Mechanisms and Implications of Reactive Oxygen Species Generation during the Unfolded Protein Response: Roles of Endoplasmic Reticulum Oxidoreductases, Mitochondrial Electron Transport, and NADPH Oxidase","volume":"11","author":"Santos","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/onc.2015.237","article-title":"Gas6\/Axl Is the Sensor of Arginine-Auxotrophic Response in Targeted Chemotherapy with Arginine-Depleting Agents","volume":"35","author":"Tsai","year":"2015","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1073\/pnas.1404171111","article-title":"Arginine Starvation-Associated Atypical Cellular Death Involves Mitochondrial Dysfunction, Nuclear DNA Leakage, and Chromatin Autophagy","volume":"111","author":"Changou","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"a004424","DOI":"10.1101\/cshperspect.a004424","article-title":"ER Stress and Its Functional Link to Mitochondria: Role in Cell Survival and Death","volume":"3","author":"Malhotra","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/bbrc.1999.1004","article-title":"Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis","volume":"261","author":"Gong","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2401763","article-title":"Arginine Deiminase Inhibits Proliferation of Human Leukemia Cells More Potently than Asparaginase by Inducing Cell Cycle Arrest and Apoptosis","volume":"14","author":"Gong","year":"2000","journal-title":"Leukemia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","article-title":"Recombinant Human Arginase Inhibits the in Vitro and in Vivo Proliferation of Human Melanoma by Inducing Cell Cycle Arrest and Apoptosis","volume":"24","author":"Lam","year":"2011","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2008.11.031","article-title":"Recombinant Human Arginase Inhibits Proliferation of Human Hepatocellular Carcinoma by Inducing Cell Cycle Arrest","volume":"277","author":"Lam","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12931-017-0564-3","article-title":"Growth Suppressive Effect of Pegylated Arginase in Malignant Pleural Mesothelioma Xenografts","volume":"18","author":"Lam","year":"2017","journal-title":"Respir. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cbi.2017.10.007","article-title":"Deciphering Molecular Mechanisms of Arginine Deiminase-Based Therapy\u2014Comparative Response Analysis in Paired Human Primary and Recurrent Glioblastomas","volume":"278","author":"Maletzki","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbrc.2010.03.066","article-title":"The Combination of ADI-PEG20 and TRAIL Effectively Increases Cell Death in Melanoma Cell Lines","volume":"394","author":"You","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ijc.23723","article-title":"Pancreatic Cancer Cell Lines Deficient in Argininosuccinate Synthetase Are Sensitive to Arginine Deprivation by Arginine Deiminase","volume":"123","author":"Bowles","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3835(01)00793-5","article-title":"Recombinant Arginine Deiminase as a Potential Anti-Angiogenic Agent","volume":"183","author":"Beloussow","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bjc.6601181","article-title":"Arginine Deiminase: A Potential Inhibitor of Angiogenesis and Tumour Growth","volume":"89","author":"Park","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1038\/onc.2016.37","article-title":"Arginine Dependence of Tumor Cells: Targeting a Chink in Cancer\u2019s Armor","volume":"35","author":"Patil","year":"2016","journal-title":"Oncogene"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12935-020-01232-9","article-title":"Arginine Deprivation: A Potential Therapeutic for Cancer Cell Metastasis? A Review","volume":"20","author":"Maalouf","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","article-title":"Pegylated Arginine Deiminase Treatment of Patients with Metastatic Melanoma: Results from Phase I and II Studies","volume":"23","author":"Ascierto","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"58948","DOI":"10.18632\/oncotarget.19564","article-title":"PEGylated Arginine Deiminase Can Modulate Tumor Immune Microenvironment by Affecting Immune Checkpoint Expression, Decreasing Regulatory T Cell Accumulation and Inducing Tumor T Cell Infiltration","volume":"8","author":"Brin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"L-Arginine Depletion Blunts Antitumor T-Cell Responses by Inducing Myeloid-Derived Suppressor Cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fimmu.2017.00864","article-title":"Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression","volume":"8","author":"Werner","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1159\/000495382","article-title":"Arginine-Depleting Enzymes\u2014An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies","volume":"51","author":"Riess","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/bjc.2012.106","article-title":"Negative Argininosuccinate Synthetase Expression in Melanoma Tumours May Predict Clinical Benefit from Arginine-Depleting Therapy with Pegylated Arginine Deiminase","volume":"106","author":"Feun","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_97","first-page":"1495","article-title":"Induction of Arginosuccinate Synthetase (ASS) Expression Affects the Antiproliferative Activity of Arginine Deiminase (ADI) in Melanoma Cells","volume":"25","author":"Manca","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","article-title":"Resistance to Arginine Deiminase Treatment in Melanoma Cells Is Associated with Induced Argininosuccinate Synthetase Expression Involving C-Myc\/HIF-1alpha\/Sp4","volume":"8","author":"Tsai","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1158\/0008-5472.CAN-11-3605","article-title":"Activation of Ras\/PI3K\/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells","volume":"72","author":"Tsai","year":"2012","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1038\/s41598-017-11445-0","article-title":"Chromatin Remodeling System P300-HDAC2-Sin3A Is Involved in Arginine Starvation-Induced HIF-1alpha Degradation at the ASS1 Promoter for ASS1 Derepression","volume":"7","author":"Tsai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1158\/1078-0432.CCR-06-1101","article-title":"In Vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion","volume":"12","author":"Szlosarek","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ijc.24546","article-title":"Epigenetic Silencing of Argininosuccinate Synthetase Confers Resistance to Platinum-Induced Cell Death but Collateral Sensitivity to Arginine Auxotrophy in Ovarian Cancer","volume":"125","author":"Nicholson","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-12-2641","article-title":"ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance","volume":"19","author":"Huang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1535-7163.MCT-13-0302","article-title":"Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction","volume":"12","author":"Long","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.celrep.2016.12.077","article-title":"Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers","volume":"18","author":"Kremer","year":"2017","journal-title":"Cell Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.bjc.6605856","article-title":"A Randomised Phase II Study of Pegylated Arginine Deiminase (ADI-PEG 20) in Asian Advanced Hepatocellular Carcinoma Patients","volume":"103","author":"Yang","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1200\/JCO.2009.26.7765","article-title":"Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma","volume":"28","author":"Glazer","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e1563","DOI":"10.1038\/cddis.2014.503","article-title":"Blocking Autophagy Enhanced Cytotoxicity Induced by Recombinant Human Arginase in Triple-Negative Breast Cancer Cells","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e2720","DOI":"10.1038\/cddis.2017.137","article-title":"A Novel and Promising Therapeutic Approach for NSCLC: Recombinant Human Arginase Alone or Combined with Autophagy Inhibitor","volume":"8","author":"Shen","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-014-0102-9","article-title":"Pegylated Arginine Deiminase Synergistically Increases the Cytotoxicity of Gemcitabine in Human Pancreatic Cancer","volume":"33","author":"Daylami","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Liu, J., Ma, J., Wu, Z., Li, W., Zhang, D., Han, L., Wang, F., Reindl, K.M., Wu, E., and Ma, Q. (2014). Arginine Deiminase Augments the Chemosensitivity of Argininosuccinate Synthetase-Deficient Pancreatic Cancer Cells to Gemcitabine via Inhibition of NF-KappaB Signaling. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-686"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"82658","DOI":"10.18632\/oncotarget.12308","article-title":"Cisplatin-Induced Synthetic Lethality to Arginine-Starvation Therapy by Transcriptional Suppression of ASS1 Is Regulated by DEC1, HIF-1alpha, and c-Myc Transcription Network and Is Independent of ASS1 Promoter DNA Methylation","volume":"7","author":"Long","year":"2016","journal-title":"Oncotarget"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.18632\/oncotarget.3370","article-title":"Targeting Argininosuccinate Synthetase Negative Melanomas Using Combination of Arginine Degrading Enzyme and Cisplatin","volume":"6","author":"Savaraj","year":"2015","journal-title":"Oncotarget"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Thongkum, A., Wu, C., Li, Y.Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Ruchirawat, M., and Savaraj, N. (2017). The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061175"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1078-0432.CCR-14-2610","article-title":"Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors","volume":"21","author":"Tomlinson","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41419-018-1195-4","article-title":"Efficacy of Arginine Depletion by ADI-PEG20 in an Intracranial Model of GBM","volume":"9","author":"Przystal","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ijc.20435","article-title":"Arginine Deiminase Enhances Dexamethasone-Induced Cytotoxicity in Human T-Lymphoblastic Leukemia CCRF-CEM Cells","volume":"112","author":"Noh","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/15384047.2015.1026478","article-title":"Arginine Deprivation by Arginine Deiminase of Streptococcus Pyogenes Controls Primary Glioblastoma Growth In Vitro and In Vivo","volume":"16","author":"Fiedler","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7150\/thno.40195","article-title":"Histone Deacetylase Inhibition Is Synthetically Lethal with Arginine Deprivation in Pancreatic Cancers with Low Argininosuccinate Synthetase 1 Expression","volume":"10","author":"Kim","year":"2020","journal-title":"Theranostics"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Shuvayeva, G.Y., Bobak, Y.P., Vovk, O.I., Kunz-Schughart, L.A., Fletcher, M.T., and Stasyk, O.V. (2020). Indospicine Combined with Arginine Deprivation Triggers Cancer Cell Death via Caspase-Dependent Apoptosis. Cell Biol. Int.","DOI":"10.1002\/cbin.11321"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"36914","DOI":"10.18632\/oncotarget.26398","article-title":"TRAIL Stabilization and Cancer Cell Sensitization to Its Pro-Apoptotic Activity Achieved through Genetic Fusion with Arginine Deiminase","volume":"9","author":"Brin","year":"2018","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/cdd.2015.174","article-title":"Onto Better TRAILs for Cancer Treatment","volume":"23","author":"Lemke","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Naval, J., de Miguel, D., Gallego-Lleyda, A., Anel, A., and Martinez-Lostao, L. (2019). Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy. Cancers, 11.","DOI":"10.3390\/cancers11040444"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.3892\/mmr.2017.7806","article-title":"Juglone Potentiates TRAIL-induced Apoptosis in Human Melanoma Cells via Activating the ROS-p38-p53 Pathway","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"27233","DOI":"10.18632\/oncotarget.25519","article-title":"Construction and Characterization of a New TRAIL Soluble Form, Active at Picomolar Concentrations","volume":"9","author":"Melendez","year":"2018","journal-title":"Oncotarget"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.7150\/thno.31157","article-title":"A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/mmr.2016.5283","article-title":"Adipose-derived Mesenchymal Stem Cell-facilitated TRAIL Expression in Melanoma Treatment in Vitro","volume":"14","author":"Jing","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Salmasi, Z., Hashemi, M., Mahdipour, E., Nourani, H., Abnous, K., and Ramezani, M. (2020). Mesenchymal Stem Cells Engineered by Modified Polyethylenimine Polymer for Targeted Cancer Gene Therapy, In Vitro and In Vivo. Biotechnol. Prog., e3025.","DOI":"10.1002\/btpr.3025"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2018.07.067","article-title":"Exosomes Derived from TRAIL-Engineered Mesenchymal Stem Cells with Effective Anti-Tumor Activity in a Mouse Melanoma Model","volume":"549","author":"Shamili","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7785\/tcrt.2012.500446","article-title":"TNF-Related Apoptosis-Inducing Ligand Delivered by RNDV Is a Novel Agent for Cancer Gene Therapy","volume":"14","author":"Bai","year":"2015","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/acsnano.7b05876","article-title":"Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy","volume":"12","author":"Guimaraes","year":"2018","journal-title":"ACS Nano"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1038\/s41418-020-0512-5","article-title":"Convergence of Pathway Analysis and Pattern Recognition Predicts Sensitization to Latest Generation TRAIL Therapeutics by IAP Antagonism","volume":"27","author":"Vetma","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/07391102.2018.1431151","article-title":"Decreasing the Immunogenicity of Arginine Deiminase Enzyme via Structure-Based Computational Analysis","volume":"37","author":"Zarei","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_134","first-page":"11","article-title":"Arginine Deprivation Therapy for Malignant Melanoma","volume":"5","author":"Yoon","year":"2013","journal-title":"Clin. Pharmacol. Adv. Appl."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7628\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:30:55Z","timestamp":1760164255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":134,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147628"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147628","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}